Literature DB >> 19507459

Patterns of pain and distress during high-dose-rate intracavity brachytherapy for cervical cancer.

Kristine L Kwekkeboom1, Nancy R Dendaas, Margaret Straub, Kristin A Bradley.   

Abstract

Over the past decade, outpatient high-dose-rate (HDR) brachytherapy has become increasingly common in the treatment of many women with cervical cancer. In our study, we explored women's experiences of pain and distress over a series of five HDR brachytherapy procedures given for cervical cancer. Seventeen patients receiving HDR cervical brachytherapy with conscious sedation for stages I-III cervical cancer completed ratings of pain intensity and distress and a measure of physical and emotional discomfort with each procedure. The majority of women reported worst pain in the mild to moderate range and similar ratings of worst distress across the series of procedures. The most physically uncomfortable aspect of treatment was removal of the instruments after the procedure, when sedatives had worn off. The most emotionally uncomfortable aspect was worry about the effects of treatment. A subset of women reported having recalled pain from previous procedures, despite the use of conscious sedation medications. Those women who recalled having had pain rated their worst pain during the procedure higher than women who did not recall having had pain. For most patients, HDR brachytherapy delivered with conscious sedation is well tolerated with only mild pain and distress. However, a small number of patients may experience more significant symptoms and may require additional medical and psychosocial support.

Entities:  

Mesh:

Year:  2009        PMID: 19507459

Source DB:  PubMed          Journal:  J Support Oncol        ISSN: 1544-6794


  6 in total

1.  Pain assessment during conscious sedation for cervical cancer high-dose-rate brachytherapy.

Authors:  H Bhanabhai; R Samant; C E; L Grenier; S Lowry
Journal:  Curr Oncol       Date:  2013-08       Impact factor: 3.677

2.  The experience of pain and anxiety in rectal cancer patients during high-dose-rate brachytherapy.

Authors:  S Néron; S Perez; R Benc; A Bellman; Z Rosberger; T Vuong
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

3.  Reporting characteristics of cancer pain: a systematic review and quantitative analysis of research publications in palliative care journals.

Authors:  Senthil P Kumar
Journal:  Indian J Palliat Care       Date:  2011-01

4.  Caudal epidural anesthesia during intracavitary brachytherapy for cervical cancer.

Authors:  Yuko Isoyama-Shirakawa; Katsumasa Nakamura; Madoka Abe; Naonobu Kunitake; Keiji Matsumoto; Saiji Ohga; Tomonari Sasaki; Satoru Uehara; Kazuhiro Okushima; Yoshiyuki Shioyama; Hiroshi Honda
Journal:  J Radiat Res       Date:  2015-04-06       Impact factor: 2.724

5.  Concurrent Chemo- Radiobrachytherapy with Cisplatin and Medium Dose Rate Intra- Cavitary Brachytherapy for Locally Advanced Uterine Cervical Cancer

Authors:  Mahdi Aghili; Bahram Andalib; Zhaleh Karimi Moghaddam; Afsaneh Maddah Safaie; Farnaz Amoozgar Hashemi; Nima Mousavi Darzikolaie
Journal:  Asian Pac J Cancer Prev       Date:  2018-10-26

6.  Exploration of gynaecological cancer high dose-rate brachytherapy treatment: a pilot study.

Authors:  Alicia Ehlers; Chandra Rekha Makanjee
Journal:  Pan Afr Med J       Date:  2018-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.